Kost, S.E.F.; Saleh, A.; Mejia, E.M.; Mostafizar, M.; Bouchard, E.D.J.; Banerji, V.; Marshall, A.J.; Gibson, S.B.; Johnston, J.B.; Katyal, S.
Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia. Cancers 2019, 11, 1519.
https://doi.org/10.3390/cancers11101519
AMA Style
Kost SEF, Saleh A, Mejia EM, Mostafizar M, Bouchard EDJ, Banerji V, Marshall AJ, Gibson SB, Johnston JB, Katyal S.
Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia. Cancers. 2019; 11(10):1519.
https://doi.org/10.3390/cancers11101519
Chicago/Turabian Style
Kost, Sara E. F., Ali Saleh, Edgard M. Mejia, Marina Mostafizar, Eric D. J. Bouchard, Versha Banerji, Aaron J. Marshall, Spencer B. Gibson, James B. Johnston, and Sachin Katyal.
2019. "Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia" Cancers 11, no. 10: 1519.
https://doi.org/10.3390/cancers11101519
APA Style
Kost, S. E. F., Saleh, A., Mejia, E. M., Mostafizar, M., Bouchard, E. D. J., Banerji, V., Marshall, A. J., Gibson, S. B., Johnston, J. B., & Katyal, S.
(2019). Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia. Cancers, 11(10), 1519.
https://doi.org/10.3390/cancers11101519